Post-licensure, Phase IV, Safety Study of IMOJEV in Thailand
Phase of Trial: Phase IV
Latest Information Update: 06 May 2016
Price : $35 *
At a glance
- Drugs Japanese encephalitis vaccine (Primary)
- Indications Japanese encephalitis
- Focus Adverse reactions
- Sponsors Sanofi
- 31 Mar 2016 primary end points has been modified.
- 31 Mar 2016 Status changed from active, no longer recruiting to completed.
- 18 Aug 2015 Planned End Date changed from 1 May 2016 to 1 Jun 2016 as per ClinicalTrials.gov record.